ArQule

Arrakis Therapeutics

This biopharmaceutical company develops oral, small-molecule medicines that target RNA to treat patients with cancer, cardiovascular conditions, neurodegeneration and rare genetic diseases.

Arcus Biosciences

This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Akanocure Pharmaceuticals

This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

Athira Pharma

This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.